Pfizer files suit against J&J over Remicade contracts
(Reuters) – Drugmaker Pfizer Inc on Wednesday filed a lawsuit against Johnson & Johnson , saying its rival’s contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and blocked sales of Pfizer’s new biosimilar.
Sika wants to step up acquisition drive
ZURICH (Reuters) – Sika’s Chief Executive, Paul Schuler, wants to accelerate the Swiss industrial and construction chemicals maker’s acquisition drive with more and bigger deals in the next 15 months.
Wall St. opens little changed; Fed takes center stage
(Reuters) – Wall Street opened little changed on Wednesday as investors waited for the conclusion of the two-day Federal Reserve meeting for indications of a third interest rate hike this year.
Toshiba to sell chip unit to Bain Capital-led group for $18 billion
TOKYO (Reuters) – Japan’s Toshiba Corp agreed on Wednesday to sell its prized semiconductor business to a group led by U.S. private equity firm Bain Capital LP, a key step in keeping the struggling Japanese conglomerate listed on the Tokyo exchange.
Pfizer sues Johnson & Johnson over Remicade biosimilar
(Reuters) – Pfizer Inc on Wednesday filed a lawsuit against Johnson & Johnson , saying that the drugmaker’s anticompetitive contracts with health insurers prevented biosimilar competition to its blockbuster rheumatoid arthritis drug, Remicade.
Clariant short-sellers squeezed as activist Corvex doubles-down
LONDON (Reuters) – Hedge funds have trimmed bets on a fall in shares of Clariant , just as activist investor Corvex increases pressure on the Swiss chemicals company to ditch a $20 billion M&A deal with rival Huntsman .
UPS expects to hire about 95,000 workers for holiday season
(Reuters) – U.S. package delivery company United Parcel Service Inc said on Wednesday it expected to hire about 95,000 seasonal employees for the upcoming, crucial peak holiday season.
As Apple slows, fast-moving Chinese rivals gain in wealthy markets
HONG KONG/SINGAPORE (Reuters) – Slowing innovation at iPhone maker Apple gives Asian rivals their best chance yet to conquer developed markets, retailers and consumers say – thanks to better designs and lower prices.
At Deutsche Boerse, time and support dwindle for CEO Kengeter
FRANKFURT (Reuters) – Support for Deutsche Boerse CEO Carsten Kengeter on the exchange group’s supervisory board is weakening as investigations into insider trading allegations drag on, according to a person with knowledge of the matter.
Futures flat as investors focus on Fed meeting
(Reuters) – U.S. stock index futures were little changed on Wednesday as investors awaited clues from the Federal Reserve meeting on whether the central bank will raise interest rates for a third time this year.
